Aclarubicin
(USZYSDMBJDPRIF-SVEJIMAYSA-N)
Structure
- SMILES
- COC(=O)[C@@H]1c2cc3c(c(c2[C@H](C[C@]1(O)CC)O[C@@H]1O[C@@H](C)[C@H]([C@H](C1)N(C)C)O[C@H]1C[C@H](O)[C@@H]([C@@H](O1)C)O[C@H]1CCC(=O)[C@@H](O1)C)O)C(=O)c1c(C3=O)cccc1O
- Type(s)
- Investigational
- ATC code(s)
- L01DB04
- Molecular Formula:
- C42H53NO15
- Molecular Weight:
- 811.868
- Log P:
- 3.1577
- Hydrogen Bond Acceptor:
- 16
- Hydrogen Bond Donor:
- 4
- TPSA:
- 217.05
- CAS Number(s):
- 57576-44-0
Synonym(s)
1.
Aclarubicin
2.
Aclacinomycin A
3.
Aclacin
4.
Aclaplastin
5.
MA-144A1
6.
NSC-208734
7.
MA 144A1
8.
MA144A1
9.
NSC 208734
10.
NSC208734
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Necrosis | 20399885 | CTD | |
| 2 | Torsades de Pointes | 1942537 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.